January 13, 2026

Menopause Alters Voice, Not Quality of Life

Postmenopausal women show lower vocal frequency and reduced perceived strain without changes to quality of life.

Conexiant

December 16, 2025

FDA OKs Addyi for Postmenopausal Women

Flibanserin approved to treat hypoactive sexual desire disorder in postmenopausal patients under 65

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

June 27, 2024

Analysis Evaluates Safety Profile of Enobosarm

A pooled analysis revealed insights on adverse events experienced by patients taking enobosarm, a selective androgen receptor modulator, vs a placebo.

Conexiant

February 26, 2025

Social Media’s Role in Medical Overdiagnosis

Researchers found that most social media posts promoting medical tests with potential for overdiagnosis predominantly focused on benefits, with limited discussion of harms or supporting scientific evidence.

Conexiant